3 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
Follow Obecabtagene Autoleucel: new trials by email Literature Review of Obecabtagene Autoleucel trials Research Report on Obecabtagene Autoleucel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia Obecabtagene Autoleucel - Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 40 | 2026-02-03 | 2026-08-20 |
| Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN) Obecabtagene autoleucel - Lupus Nephritis | Phase 2 | Recruiting | Autolus Limited | 35 | 2026-01-16 | 2026-08-24 |
| Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL) Obecabtagene autoleucel - Acute Lymphocytic Leukemia (ALL) | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 30 | 2025-08-26 | 2026-08-12 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1)
Autolus Limited (1) · M.D. Anderson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1)
United States (3) · Brazil (1) · Greece (1) · United Kingdom (1) · Vietnam (1)